Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$12.65
+0.60%
Mkt Cap $3.99B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 27, 2026 | $807.35M | $814.32M | +0.86% | $0.18 | $0.21 | +16.67% | — | — |
| Q4 2025 Oct 30, 2025 | $806.07M | $784.51M | -2.67% | $0.13 | $0.17 | +30.77% | — | — |
| Q3 2025 Aug 5, 2025 | $768.60M | $724.51M | -5.74% | $0.18 | $0.25 | +38.89% | — | — |
| Q2 2025 May 2, 2025 | $744.23M | $695.42M | -6.56% | $0.15 | $0.21 | +40.00% | — | — |
| Q1 2025 Feb 28, 2025 | $723.09M | $730.52M | +1.03% | $0.15 | $0.12 | -20.00% | — | — |
| Q4 2024 Nov 8, 2024 | $700.83M | $702.47M | +0.23% | $0.13 | $0.16 | +23.08% | — | — |
| Q3 2024 Aug 9, 2024 | $658.14M | $701.78M | +6.63% | $0.14 | $0.16 | +14.29% | — | — |
| Q2 2024 May 3, 2024 | — | $659.19M | — | $0.09 | $0.14 | +55.56% | — | — |
| Q1 2024 Mar 1, 2024 | $663.56M | $616.98M | -7.02% | $0.07 | $0.14 | +100.00% | — | — |
| Q4 2023 Nov 7, 2023 | $634.23M | $620.04M | -2.24% | $0.12 | $0.19 | +58.33% | — | — |
| Q3 2023 Aug 4, 2023 | $565.41M | $599.05M | +5.95% | $0.10 | $0.19 | +90.00% | — | — |
| Q2 2023 May 5, 2023 | $537.31M | $557.54M | +3.77% | $0.09 | $0.12 | +33.33% | — | — |
| Q1 2023 Mar 2, 2023 | $562.15M | $609.76M | +8.47% | $0.21 | $0.23 | +9.52% | — | — |
| Q4 2022 Nov 4, 2022 | — | $545.56M | — | $0.18 | $0.14 | -22.22% | — | — |
| Q3 2022 Aug 5, 2022 | — | $559.36M | — | $0.20 | $0.19 | -5.00% | — | — |
| Q2 2022 May 4, 2022 | $535.91M | $497.63M | -7.14% | $0.12 | $0.12 | +0.00% | — | — |
| Q1 2022 Mar 2, 2022 | $502.29M | $536.90M | +6.89% | $0.19 | $0.18 | -5.26% | — | — |
| Q4 2021 Nov 3, 2021 | $544.49M | $528.59M | -2.92% | $0.20 | $0.21 | +5.00% | — | — |
| Q3 2021 Aug 9, 2021 | $535.08M | $535.08M | +0.00% | $0.18 | $0.25 | +38.89% | — | — |
| Q2 2021 May 7, 2021 | $438.32M | $493.11M | +12.50% | $0.18 | $0.20 | +11.11% | — | — |